Ribonucleic Acid (RNA) And Deoxyribonucleic Acid (DNA) Magnetic Purification Kits Market Global Report 2026

The ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) magnetic purification kits market size has grown exponentially in recent years. It will grow from $1.47 billion in 2025 to $1.84 billion in 2026 at a compound annual growth rate (CAGR) of 24.8%. The growth in the historic period can be attributed to the increasing demand for molecular diagnostics, the rising adoption of genomics research applications, the growing need for efficient nucleic acid extraction methods, the expanding biotechnology and pharmaceutical research activities, and the increasing utilization of laboratory automation systems.

The ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) magnetic purification kits market size is expected to see exponential growth in the next few years. It will grow to $4.4 billion in 2030 at a compound annual growth rate (CAGR) of 24.4%. The growth in the forecast period can be attributed to increasing demand for personalized medicine and precision diagnostics, rising adoption of automated high-throughput purification platforms, growing research activities in genetic analysis and molecular biology, expanding clinical testing applications, and increasing investments in biotechnology and life science infrastructure. Major trends in the forecast period include growing adoption of high-throughput magnetic bead-based nucleic acid purification workflows, increasing development of automated nucleic acid extraction platforms for improved laboratory efficiency, rising demand for rapid and reproducible molecular sample preparation solutions, expanding utilization of magnetic purification kits in infectious disease testing and research, and increasing availability of specialized purification kits for diverse biological sample types.

The increasing adoption of precision medicine is expected to propel the growth of the ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) magnetic purification kits market in the forecast period. Precision medicine refers to a healthcare approach that customizes disease prevention, diagnosis, and treatment strategies based on an individual’s genetic, molecular, and clinical characteristics. The adoption of precision medicine is expanding due to advancements in genomics and molecular diagnostics, which enable the development of personalized treatment approaches based on an individual’s genetic profile, improving therapeutic effectiveness and minimizing adverse effects. Ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) magnetic purification kits support personalized medicine by enabling rapid and high-quality extraction of genetic materials from patient samples, facilitating accurate genomic and transcriptomic analysis for identifying disease-related mutations, predicting treatment responses, and developing targeted therapies based on individual molecular profiles. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, representing a significant increase compared with the six approvals recorded in 2022. Therefore, the increasing adoption of precision medicine is driving the growth of the ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) magnetic purification kits market.

Companies operating in the ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) magnetic purification kits market are focusing on developing innovative products, such as magnetic bead-based purification kits, to improve extraction efficiency, workflow flexibility, and reproducibility in molecular biology applications. Magnetic bead-based purification kits are advanced sample preparation tools that utilize silica-coated magnetic particles to selectively bind DNA and RNA molecules, enabling rapid, high-purity nucleic acid isolation through magnetic separation rather than traditional centrifugation or column-based methods. In April 2026, Ferrotec (USA) Corporation, a US-based manufacturing company, launched the Ferrobeads DNA/RNA Isolation Kit designed for high-efficiency nucleic acid extraction. The kit utilizes silica-coated magnetic beads with a large surface area and high magnetic content to enhance binding efficiency and provide consistent DNA and RNA yields across a wide range of sample types, including blood, plant tissue, and cell cultures. It is compatible with both manual and automated workflows, providing open-platform flexibility without reliance on proprietary instruments, which reduces operational constraints and costs. Additionally, the system enables rapid extraction within approximately 10-25 minutes and supports downstream applications such as PCR and RT-PCR, enhancing laboratory productivity and reliability in molecular research workflows.

In December 2023, PerkinElmer Inc., a US-based technology company, acquired Covaris LLC for an undisclosed amount. Through this acquisition, PerkinElmer aimed to strengthen and broaden its life sciences and diagnostics portfolio by integrating Covaris’ advanced sample preparation technologies, including its Adaptive Focused Acoustics (AFA) platform, thereby enhancing its capabilities in genomics, proteomics, and next-generation sequencing workflows across research and clinical applications. Covaris LLC is a US-based biotechnology company that specializes in providing RNA and DNA magnetic purification kits.

Major companies operating in the ribonucleic acid (rna) and deoxyribonucleic acid (dna) magnetic purification kits market are Thermo Fisher Scientific Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., QIAGEN N.V., Merck KGaA, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Revvity Inc., Promega Corporation, Takara Bio Inc., New England Biolabs Inc., Corning Incorporated, LGC Limited, Macherey-Nagel GmbH & Co. KG, Miltenyi Biotec B.V. & Co. KG, Zymo Research Corporation, Analytik Jena GmbH+Co. KG, Enzo Biochem Inc., Bioneer Corporation, MagBio Genomics Inc., Geneaid Ltd., Norgen Biotek Corp., Omega Bio-tek Inc., Creative Diagnostics Inc.

North America was the dominating region in the ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) magnetic purification kits market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) magnetic purification kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) magnetic purification kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.